1.7.2.3	additional information	-	-	392755, 392765, 392768, 392770, 392775	
1.7.2.3	additional information	-	specific activity in extracts after growth on various oxide compounds	392761	
1.7.2.3	0.096	-	anaerobic growth conditions, grown without trimethylamine N-oxide	392768	
1.7.2.3	0.13	-	periplasmic fraction	392772	
1.7.2.3	0.163	-	microaerobic growth conditions, grown without trimethylamine N-oxide	392768	
1.7.2.3	0.25	-	aerobic growth conditions, grown with trimethylamine N-oxide	392768	
1.7.2.3	0.374	-	anaerobic growth conditions, grown with trimethylamine N-oxide	392768	
1.7.2.3	0.41	-	mutants, which reduce little or no trimethylamine N-oxide in vivo, but their extracts retain full capacity to reduce it with methyl viologen, formate as electron donor	392770	
1.7.2.3	0.56	-	microaerobic growth conditions, grown with trimethylamine N-oxide	392768	
1.7.2.3	0.66	-	mutants partially defective in trimethylamine N-oxide reductase activity, which lack the inducible enzyme but retain the constitutive activity, FMN or vitamin K5 as electron donor	392770	
1.7.2.3	1.29	-	mutants partially defective in trimethylamine N-oxide reductase activity, which lack the inducible enzyme but retain the constitutive activity, formate as electron donor	392770	
1.7.2.3	1.56	-	wild-type strain, formate as electron donor	392770	
1.7.2.3	2.63	-	mutants, which reduce little or no trimethylamine N-oxide in vivo, but their extracts retain full capacity to reduce it with methyl viologen, vitamin K5 as electron donor	392770	
1.7.2.3	3.73	-	wild-type strain, vitamin K5 as electron donor	392770	
1.7.2.3	3.77	-	mutants, which reduce little or no trimethylamine N-oxide in vivo, but their extracts retain full capacity to reduce it with methyl viologen, FMN as electron donor	392770	
1.7.2.3	4.31	-	mutants partially defective in trimethylamine N-oxide reductase activity, which lack the inducible enzyme but retain the constitutive activity, methyl viologen as electron donor	392770	
1.7.2.3	4.7	-	wild-type strain, FMN as electron donor	392770	
1.7.2.3	6.8	-	-	437737	
1.7.2.3	9.92	-	wild-type strain, methyl viologen as electron donor	392770	
1.7.2.3	10.2	-	purified enzyme	392772	
1.7.2.3	11	-	periplasmic fraction of wild-type cells, initial activity	392774	
1.7.2.3	11	-	without trimethylamine N-oxide, cell free extract, aerobic conditions	392764	
1.7.2.3	11.2	-	mutants, which reduce little or no trimethylamine N-oxide in vivo, but their extracts retain full capacity to reduce it with methyl viologen, methyl viologen as electron donor	392770	
1.7.2.3	30	-	-	437735	
1.7.2.3	33	-	purified enzyme, assay performed in 100 mM phosphate buffer, pH 6.8 with a trimethylamine N-oxide concentration 0.5 mM and a concentration 20 mM of 2-hydroxypyridine N-oxide	392773	
1.7.2.3	34	-	purified enzyme, assay performed in 100 mM phosphate buffer, pH 6.8 with a trimethylamine N-oxide concentration 0.5 mM	392773	
1.7.2.3	35	-	purified enzyme, assay performed in 100 mM phosphate buffer, pH 6.8 with a trimethylamine N-oxide concentration 0.5 mM and a concentration 20 mM of tetramethylenesulfoxide	392773	
1.7.2.3	36	-	purified enzyme, assay performed in 100 mM phosphate buffer, pH 6.8 with a trimethylamine N-oxide concentration 0.5 mM and a concentration 20 mM of picolinic acid N-oxide or a concentration 20 mM of dimethylsulfoxide	392773	
1.7.2.3	41	-	purified tungsten-substituted enzyme	392776	
1.7.2.3	49.5	-	-	437730	
1.7.2.3	70	-	30 mM trimethylamine N-oxide, cell free extract, aerobic conditions	392764	
1.7.2.3	105	-	purified enzyme, with trimethylamine N-oxide as substrate	392773	
1.7.2.3	211.5	-	-	392758	
1.7.2.3	237	-	-	392765	
1.7.2.3	250	-	purified enzyme	392774	
1.7.2.3	320	-	30 mM trimethylamine N-oxide, cell free extract, anaerobic conditions	392764	
1.7.2.3	1350	-	crude extract of mutant strain lacking the TorD protein	392774	
1.7.2.3	1620	-	-	392757	
1.7.2.3	1720	-	crude extract of wild-type strain	392774	
1.7.2.3	1810	-	crude extract of mutant strain lacking the TorD protein but complemented by pTorD	392774